According to sources:
“He has deep legal expertise and is also a trusted business adviser with a very practical view of solving issues.”
"Luke is a prompt and good communicator.”
“He's very responsive and gets to the heart of an issue quickly.”
“Luke is terrific and commercially minded.”

Chambers USA 2021

Luke J. Bergstrom

San Francisco | Silicon Valley
  • 505 Montgomery Street
  • Suite 2000
  • San Francisco, CA 94111-6538
  • USA
 
 

Luke Bergstrom, Global Vice Chair of the firm's Technology Industry Group and former Global Co-Chair of the Mergers & Acquisitions Practice, regularly advises leading corporate and private equity clients on significant M&A transactions and related sensitive matters.

Mr. Bergstrom advises companies and private equity firms, drawing on more than two decades of experience handling a full spectrum of transactions. He combines strong negotiation skills, a deep commercial sensibility, and a proven ability to lead teams that leverage the firm’s global resources to help clients achieve their objectives in the most effective and cost-efficient manner.

Consistently ranked among the top M&A lawyers in the country, clients describe him as a “sophisticated, pragmatic” lawyer who “looks for solutions and wants to facilitate a deal.”

Mr. Bergstrom’s recent experience includes transactions in the following industries:

Software and Information Technology

  • Intuit Inc., a provider of business and financial management solutions for small businesses, consumers, and accounting professionals, in numerous transactions, including its:
    • US$12 billion acquisition of Mailchimp
    • US$7.1 billion acquisition of Credit Karma
    • US$340 million acquisition of TSheets, Inc.
    • US$1.025 billion sale of Digital Insight, Intuit’s Financial Services division, to Thoma Bravo
    • US$423 million acquisition of Demandforce, Inc. and its subsequent sale to Internet Brands
    • US$360 million acquisition of Check
  • Neudesic, a leading cloud services consultancy, in its sale to IBM
  • Astound Commerce, a global digital commerce specialist, in its sale of a majority interest to RLH Equity Partners
  • PriceSpider, a leading brand commerce company revolutionizing retail data technology, in its sale of a majority interest to Frontier Capital
  • Pipedrive, a sales CRM Platform, in its sale of a majority interest to Vista Equity Partners
  • Bread Financial (formerly Alliance Data Systems), in various transactions, including the sale of its Epsilon business unit to Publicis Group

Internet & Digital Media

  • Indeed.com, the American worldwide employment website for job listings, in various acquisitions
  • Khosla Ventures Acquisition Co. II in its deSPAC merger with NextDoor, the online neighborhood network
  • Chess.com, one of the world's largest online chess platforms, in its sale of a substantial growth investment to General Atlantic
  • OpenTable, Inc., a web-based service provider of restaurant reservations, in its US$2.6 billion sale to the Priceline Group
  • Twitch Interactive, Inc., an operator of a live video platform for online gaming, in its US$970 million sale to a multi-national technology company
  • eBay Inc. in its US$945 million acquisition of Bill Me Later, Inc.
  • Seamless North America, LLC, a leading provider of mobile and online portals that provide restaurant information and services, in its merger with GrubHub

Semiconductors

  • Avago Technologies Limited, a provider of analog semiconductors, custom chips, radio-frequency and microwave components, in its:
    • US$37 billion acquisition of Broadcom Corp.
    • US$6.6 billion acquisition of LSI Corporation
    • US$400 million acquisition of CyOptics
    • US$240 million sale of its Printer ASICs business to Marvell Technology Group Ltd.
    • US$70 million sale of its CMOS image sensor business to Micron Technology
  • IXYS Corporation, a provider of power semiconductors, radio frequency power semiconductors, and digital and analog integrated circuits, in various transactions, including its sale to Littelfuse

Life Sciences

  • Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company, in its acquisition by Merck
  • MAP Pharmaceuticals, Inc., a drug and pharmaceutical company, in its US$958 million sale to Allergan, Inc.
  • Labrys Biologics, Inc., a biotechnology firm developing antibody treatments for chronic migraines, in its US$825 million sale to Teva Pharmaceutical Industries
  • FerroKin BioSciences, Inc., a biotechnology company, in its US$325 million sale to Shire plc
  • KAI Pharmaceuticals, a privately held pharmaceuticals company, in its US$315 million sale to Amgen
  • Complete Genomics, Inc., a developer of DNA sequencing products and services, in its US$117 million sale to BGI Shenzhen
  • Pionyr Immunotherapeutics, a clinical stage company developing cancer therapies, in its negotiation with Gilead Sciences of a structured financing and option to purchase Pionyr
  • Transcept Pharmaceuticals, a specialty pharmaceutical company focused on the development and commercialization of proprietary products in the neuroscience field, in its reverse merger with Paratek Pharmaceuticals

Medical Devices

  • Sorin S.p.A., a global medical device company, in its US$2.7 billion merger with Cyberonics
  • Ulthera, a medical device company focused on the development and commercialization of various technologies for aesthetic and medical applications, in its:
    • US$600 million sale to Merz
    • Acquisition of Cabochon Aesthetics
  • Sadra Medical, Inc., a company pioneering new therapies to minimize the invasiveness of treating aortic valve disease, in its US$450 million sale to Boston Scientific Corporation
  • Maya Medical, a nascent hypertension product company, in its US$230 million sale to Covidien
  • Zonare Medical Systems, a US based ultrasound company, in its US$105 million sale to Mindray Medical International Limited
  • FlowCardia, Inc., a California medical device company, in its sale to C. R. Bard, Inc.
  • Hotspur Technologies, Inc., a developer of catheter-based technologies, in its sale to Teleflex Medical, Inc.
  • Harpoon Medical, a medical device company focused on the treatment of heart disease, in its negotiation with Edwards Lifesciences of a structured financing and option to purchase Harpoon
  • Kalila Medical, a medical device company developing steerable catheter technologies for atrial fibrillation and other electrophysiology procedures, in its sale to Abbott Laboratories

Private Equity

Mr. Bergstrom’s private equity experience includes:

  • ArchiMed SAS and its various portfolio companies in numerous transactions, including ArchiMed’s pending acquisition of Natus Medical
  • The Veritas Capital Vantage Fund and its various portfolio companies in numerous acquisitions
  • Behrman Capital in various transactions, including most recently, its sales of Pelican Products, New ILC Dover and Data Device Corporation
  • SRS Acquiom in its sale of a majority interest to Lovell Minnick Partners
  • Canada Pension Plan Investment Board, in its acquisition of a 48% stake in GlobalLogic, Inc. a global leader in digital product development services
  • Bridgepoint Advisers, in its acquisition with Summit Partners of Calypso Technology, a provider of financial market software solutions
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.